These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25096663)

  • 1. HIV pre-exposure prophylaxis.
    Sharma M; Tan DH
    CMAJ; 2014 Oct; 186(15):E588. PubMed ID: 25096663
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of antiretroviral drugs to prevent sexual transmission of HIV.
    Cohen MS; Hosseinipour M; Kashuba A; Butera S
    Curr Clin Top Infect Dis; 2002; 22():214-51. PubMed ID: 12520656
    [No Abstract]   [Full Text] [Related]  

  • 3. Post-exposure prophylaxis for HIV following possible sexual transmission: an ethical evaluation.
    Gisondi MA
    Camb Q Healthc Ethics; 2000; 9(3):411-7. PubMed ID: 10858892
    [No Abstract]   [Full Text] [Related]  

  • 4. Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care.
    Tung EL; Thomas A; Eichner A; Shalit P
    Sex Health; 2018 Nov; 15(6):556-561. PubMed ID: 30401342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National guidelines for post-exposure prophylaxis after non-occupational exposure to HIV.
    ; Savage J
    Sex Health; 2007 Dec; 4(4):277-83. PubMed ID: 18200764
    [No Abstract]   [Full Text] [Related]  

  • 6. Postexposure prophylaxis against human immunodeficiency virus infection after sexual assault.
    Weinberg GA
    Pediatr Infect Dis J; 2002 Oct; 21(10):959-60. PubMed ID: 12394821
    [No Abstract]   [Full Text] [Related]  

  • 7. Preventing HIV-1 sexual transmission--not sexy enough science, or no benefit to the bottom line?
    Moore JP; Shattock RJ
    J Antimicrob Chemother; 2003 Dec; 52(6):890-2. PubMed ID: 14613946
    [No Abstract]   [Full Text] [Related]  

  • 8. Uptake of biomedical interventions for prevention of sexually transmitted HIV.
    Abbas UL
    Curr Opin HIV AIDS; 2011 Mar; 6(2):114-8. PubMed ID: 21505385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nurse-led pre-exposure prophylaxis: a non-traditional model to provide HIV prevention in a resource-constrained, pragmatic clinical trial.
    Schmidt HA; McIver R; Houghton R; Selvey C; McNulty A; Varma R; Grulich AE; Holden J
    Sex Health; 2018 Nov; 15(6):595-597. PubMed ID: 30257752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbicide data show promise.
    AIDS Patient Care STDS; 2009 Mar; 23(3):223-4. PubMed ID: 19480060
    [No Abstract]   [Full Text] [Related]  

  • 11. Human Immunodeficiency Virus Prevention With Preexposure Prophylaxis in Sexually Transmitted Disease Clinics.
    Hoover KW; Ham DC; Peters PJ; Smith DK; Bernstein KT
    Sex Transm Dis; 2016 May; 43(5):277-82. PubMed ID: 27100762
    [No Abstract]   [Full Text] [Related]  

  • 12. Likely impact of pre-exposure prophylaxis on HIV epidemics among men who have sex with men.
    Zablotska IB
    Sex Health; 2017 Feb; 14(1):97-105. PubMed ID: 27883309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is HIV drug resistance a limiting factor in the development of anti-HIV NNRTI and NRTI-based vaginal microbicide strategies?
    Martinez J; Coplan P; Wainberg MA
    Antiviral Res; 2006 Sep; 71(2-3):343-50. PubMed ID: 16787667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral-based HIV prevention strategies for women.
    Chirenje ZM; Marrazzo J; Parikh UM
    Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1177-86. PubMed ID: 20954882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV Pre-Exposure Prophylaxis - Is it just about pills?
    Fernandez-Montero JV
    AIDS Rev; 2016; 18(4):222. PubMed ID: 27918570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Ideal' microbicide may be best form of protection.
    AIDS Alert; 1999 Feb; 14(2):suppl 3-4. PubMed ID: 11366179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposed recommendations for the management of HIV post-exposure prophylaxis after sexual, injecting drug or other exposures in Europe.
    Almeda J; Casabona J; Simon B; Gerard M; Rey D; Puro V; Thomas T;
    Euro Surveill; 2004 Jun; 9(6):35-40. PubMed ID: 15223890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-exposure prophylaxis rollout in a national public sector program: the Kenyan case study.
    Masyuko S; Mukui I; Njathi O; Kimani M; Oluoch P; Wamicwe J; Mutegi J; Njogo S; Anyona M; Muchiri P; Maikweki L; Musyoki H; Bahati P; Kyongo J; Marwa T; Irungu E; Kiragu M; Kioko U; Ogando J; Were D; Bartilol K; Sirengo M; Mugo N; Baeten JM; Cherutich P; PrEP Technical Working Group OBOT
    Sex Health; 2018 Nov; 15(6):578-586. PubMed ID: 30408432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study.
    Kahn JO; Martin JN; Roland ME; Bamberger JD; Chesney M; Chambers D; Franses K; Coates TJ; Katz MH
    J Infect Dis; 2001 Mar; 183(5):707-14. PubMed ID: 11181146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to sexual health services after the rapid roll out of the launch of pre-exposure prophylaxis for HIV in Melbourne, Australia: a retrospective cross-sectional analysis.
    Needleman R; Chow EPF; Towns JM; Cornelisse VJ; Yang TZT; Chen MY; Bradshaw CS; Fortune R; Fairley CK
    Sex Health; 2018 Nov; 15(6):528-532. PubMed ID: 29973331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.